Baricitinib 2 MG ( DrugBank: Baricitinib )

---

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
53	Sjogren syndrome	1

46. Malignant rheumatoid arthritis

---

Clinical trials : 4,356 /  Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05660655 (ClinicalTrials.gov)	September 1, 2022	13/12/2022	Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis	Efficacy and Safety of Baricitinib in Different Doses for the Treatment of Moderate to Severe Rheumatoid Arthritis	Rheumatoid Arthritis	Drug: Baricitinib 4 MG;Drug: Baricitinib 2 MG	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	NULL	Recruiting	18 Years	N/A	All	94	Phase 4	Bangladesh

53. Sjogren syndrome

---

Clinical trials : 305 /  Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04916756 (ClinicalTrials.gov)	January 16, 2020	1/6/2021	A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients	A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients	Sjogren's Syndrome	Drug: Baricitinib 2 MG	Peking Union Medical College Hospital	NULL	Completed	18 Years	N/A	All	11	Phase 1/Phase 2	China